DuPont CEO Outlines its Priorities

Zacks

DuPont’s (DD) CEO and Chair announced, at the Strategic Decisions Conference that its “Integrated Science" strives to deliver value to customers and shareholders and provides it an advantage like no other companies.

Agricultural sciences, biosciences and material sciences, these are the three scientific strength areas of DuPont that are well integrated across the company. These segments provide unique solutions to customers' problems and create value for the shareholders. The CEO emphasized that DuPont has worked for improving fuel efficiency, creating advanced biofuels, improving food quality and growing applications of renewably sourced polymers.   

DuPont’s CEO further pointed out its strategic priorities for delivering greater shareholder returns. DuPont remains committed to extending its leadership in the science-driven segments of the agriculture-to-food value chains and leverages the linkages across these segments. It also focuses on offering unique and, high-value advanced materials through science-based solutions and create transformational, new bio-based businesses like biofuels and biomaterials.

Over the past five years, DuPont has increased its research and development by about 50%. The company also allocates more cash to those businesses which give higher returns. Thus DuPont’s strategy of allocating resources speeds up science-driven innovations for customers and increases the value for its shareholders.

DuPont is a global chemical and life sciences company and provides innovative products, materials, and services to the global market. The company beat expectations in first-quarter 2013 on the strength of its agriculture business, reflected by strong corn seeds and crop protection products sales.

DuPont currently retains a Zacks Rank #3 (hold).

Other companies in the chemical industry that are worth considering include Shin-Etsu Chemical Co., Ltd. (SHECY), Celanese Corporation (CE) and Methanex Corp. (MEOH). All of them retain a Zacks Rank #1 (Strong Buy).
 

Read the Full Research Report on DD

Read the Full Research Report on MEOH

Read the Full Research Report on CE

Read the Full Research Report on SHECY

Zacks Investment Research



More From Zacks.com
View Comments (0)